Global Point-of-care Testing (POCT) for Inflammatory Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 140

Published Date: 11 Jan 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Point-of-care Testing (POCT) for Inflammatory market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Point-of-care Testing (POCT) for Inflammatory industry chain, the market status of C-Reactive Protein (CRP) Test (Based on Immunochromatography, Based on Chemiluminescence), Procalcitonin (PCT) Test (Based on Immunochromatography, Based on Chemiluminescence), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Point-of-care Testing (POCT) for Inflammatory.

Regionally, the report analyzes the Point-of-care Testing (POCT) for Inflammatory markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Point-of-care Testing (POCT) for Inflammatory market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Point-of-care Testing (POCT) for Inflammatory market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Point-of-care Testing (POCT) for Inflammatory industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Based on Immunochromatography, Based on Chemiluminescence).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Point-of-care Testing (POCT) for Inflammatory market.

Regional Analysis: The report involves examining the Point-of-care Testing (POCT) for Inflammatory market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Point-of-care Testing (POCT) for Inflammatory market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Point-of-care Testing (POCT) for Inflammatory:
Company Analysis: Report covers individual Point-of-care Testing (POCT) for Inflammatory manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Point-of-care Testing (POCT) for Inflammatory This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (C-Reactive Protein (CRP) Test, Procalcitonin (PCT) Test).

Technology Analysis: Report covers specific technologies relevant to Point-of-care Testing (POCT) for Inflammatory. It assesses the current state, advancements, and potential future developments in Point-of-care Testing (POCT) for Inflammatory areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Point-of-care Testing (POCT) for Inflammatory market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Point-of-care Testing (POCT) for Inflammatory market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Based on Immunochromatography
Based on Chemiluminescence
Based on Microfluidic Chip

Market segment by Application
C-Reactive Protein (CRP) Test
Procalcitonin (PCT) Test
Interleukin 6 (IL-6) Test
Serum amyloid A (SAA) Test
Others

Major players covered
Roche
Abbott
Siemens Healthineers
BioMerieux
Bio-Rad Laboratories
Assure Tech
Guangzhou Wondfo Biotech Co.,Ltd.
Wuhan Easy Diagnosis
Getein Biotech
Beijing Hotgen Biotech Co.,ltd.
Shanghai Upper Bio-Tech Pharma Co.,Ltd.
Qingdao Hightop Biotech Co., Ltd.
Goldsite Diagnostics Inc.
Genrui Biotech Inc
Hipro Biotechnology CO.,LTD

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Point-of-care Testing (POCT) for Inflammatory product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Point-of-care Testing (POCT) for Inflammatory, with price, sales, revenue and global market share of Point-of-care Testing (POCT) for Inflammatory from 2019 to 2024.
Chapter 3, the Point-of-care Testing (POCT) for Inflammatory competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Point-of-care Testing (POCT) for Inflammatory breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Point-of-care Testing (POCT) for Inflammatory market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Point-of-care Testing (POCT) for Inflammatory.
Chapter 14 and 15, to describe Point-of-care Testing (POCT) for Inflammatory sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Point-of-care Testing (POCT) for Inflammatory
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Based on Immunochromatography
        1.3.3 Based on Chemiluminescence
        1.3.4 Based on Microfluidic Chip
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 C-Reactive Protein (CRP) Test
        1.4.3 Procalcitonin (PCT) Test
        1.4.4 Interleukin 6 (IL-6) Test
        1.4.5 Serum amyloid A (SAA) Test
        1.4.6 Others
    1.5 Global Point-of-care Testing (POCT) for Inflammatory Market Size & Forecast
        1.5.1 Global Point-of-care Testing (POCT) for Inflammatory Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity (2019-2030)
        1.5.3 Global Point-of-care Testing (POCT) for Inflammatory Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Roche
        2.1.1 Roche Details
        2.1.2 Roche Major Business
        2.1.3 Roche Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.1.4 Roche Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Roche Recent Developments/Updates
    2.2 Abbott
        2.2.1 Abbott Details
        2.2.2 Abbott Major Business
        2.2.3 Abbott Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.2.4 Abbott Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Abbott Recent Developments/Updates
    2.3 Siemens Healthineers
        2.3.1 Siemens Healthineers Details
        2.3.2 Siemens Healthineers Major Business
        2.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.3.4 Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Siemens Healthineers Recent Developments/Updates
    2.4 BioMerieux
        2.4.1 BioMerieux Details
        2.4.2 BioMerieux Major Business
        2.4.3 BioMerieux Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.4.4 BioMerieux Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 BioMerieux Recent Developments/Updates
    2.5 Bio-Rad Laboratories
        2.5.1 Bio-Rad Laboratories Details
        2.5.2 Bio-Rad Laboratories Major Business
        2.5.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.5.4 Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Bio-Rad Laboratories Recent Developments/Updates
    2.6 Assure Tech
        2.6.1 Assure Tech Details
        2.6.2 Assure Tech Major Business
        2.6.3 Assure Tech Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.6.4 Assure Tech Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Assure Tech Recent Developments/Updates
    2.7 Guangzhou Wondfo Biotech Co.,Ltd.
        2.7.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
        2.7.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
        2.7.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.7.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
    2.8 Wuhan Easy Diagnosis
        2.8.1 Wuhan Easy Diagnosis Details
        2.8.2 Wuhan Easy Diagnosis Major Business
        2.8.3 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.8.4 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Wuhan Easy Diagnosis Recent Developments/Updates
    2.9 Getein Biotech
        2.9.1 Getein Biotech Details
        2.9.2 Getein Biotech Major Business
        2.9.3 Getein Biotech Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.9.4 Getein Biotech Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Getein Biotech Recent Developments/Updates
    2.10 Beijing Hotgen Biotech Co.,ltd.
        2.10.1 Beijing Hotgen Biotech Co.,ltd. Details
        2.10.2 Beijing Hotgen Biotech Co.,ltd. Major Business
        2.10.3 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.10.4 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
    2.11 Shanghai Upper Bio-Tech Pharma Co.,Ltd.
        2.11.1 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Details
        2.11.2 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Major Business
        2.11.3 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.11.4 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments/Updates
    2.12 Qingdao Hightop Biotech Co., Ltd.
        2.12.1 Qingdao Hightop Biotech Co., Ltd. Details
        2.12.2 Qingdao Hightop Biotech Co., Ltd. Major Business
        2.12.3 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.12.4 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
    2.13 Goldsite Diagnostics Inc.
        2.13.1 Goldsite Diagnostics Inc. Details
        2.13.2 Goldsite Diagnostics Inc. Major Business
        2.13.3 Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.13.4 Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Goldsite Diagnostics Inc. Recent Developments/Updates
    2.14 Genrui Biotech Inc
        2.14.1 Genrui Biotech Inc Details
        2.14.2 Genrui Biotech Inc Major Business
        2.14.3 Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.14.4 Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Genrui Biotech Inc Recent Developments/Updates
    2.15 Hipro Biotechnology CO.,LTD
        2.15.1 Hipro Biotechnology CO.,LTD Details
        2.15.2 Hipro Biotechnology CO.,LTD Major Business
        2.15.3 Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Product and Services
        2.15.4 Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Hipro Biotechnology CO.,LTD Recent Developments/Updates

3 Competitive Environment: Point-of-care Testing (POCT) for Inflammatory by Manufacturer
    3.1 Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Point-of-care Testing (POCT) for Inflammatory Revenue by Manufacturer (2019-2024)
    3.3 Global Point-of-care Testing (POCT) for Inflammatory Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Inflammatory by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Point-of-care Testing (POCT) for Inflammatory Manufacturer Market Share in 2023
        3.4.2 Top 6 Point-of-care Testing (POCT) for Inflammatory Manufacturer Market Share in 2023
    3.5 Point-of-care Testing (POCT) for Inflammatory Market: Overall Company Footprint Analysis
        3.5.1 Point-of-care Testing (POCT) for Inflammatory Market: Region Footprint
        3.5.2 Point-of-care Testing (POCT) for Inflammatory Market: Company Product Type Footprint
        3.5.3 Point-of-care Testing (POCT) for Inflammatory Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Point-of-care Testing (POCT) for Inflammatory Market Size by Region
        4.1.1 Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Region (2019-2030)
        4.1.2 Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Region (2019-2030)
        4.1.3 Global Point-of-care Testing (POCT) for Inflammatory Average Price by Region (2019-2030)
    4.2 North America Point-of-care Testing (POCT) for Inflammatory Consumption Value (2019-2030)
    4.3 Europe Point-of-care Testing (POCT) for Inflammatory Consumption Value (2019-2030)
    4.4 Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Consumption Value (2019-2030)
    4.5 South America Point-of-care Testing (POCT) for Inflammatory Consumption Value (2019-2030)
    4.6 Middle East and Africa Point-of-care Testing (POCT) for Inflammatory Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2019-2030)
    5.2 Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Type (2019-2030)
    5.3 Global Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2019-2030)
    6.2 Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Application (2019-2030)
    6.3 Global Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2019-2030)

7 North America
    7.1 North America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2019-2030)
    7.2 North America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2019-2030)
    7.3 North America Point-of-care Testing (POCT) for Inflammatory Market Size by Country
        7.3.1 North America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Country (2019-2030)
        7.3.2 North America Point-of-care Testing (POCT) for Inflammatory Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2019-2030)
    8.2 Europe Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2019-2030)
    8.3 Europe Point-of-care Testing (POCT) for Inflammatory Market Size by Country
        8.3.1 Europe Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Country (2019-2030)
        8.3.2 Europe Point-of-care Testing (POCT) for Inflammatory Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Market Size by Region
        9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2019-2030)
    10.2 South America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2019-2030)
    10.3 South America Point-of-care Testing (POCT) for Inflammatory Market Size by Country
        10.3.1 South America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Country (2019-2030)
        10.3.2 South America Point-of-care Testing (POCT) for Inflammatory Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Market Size by Country
        11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Point-of-care Testing (POCT) for Inflammatory Market Drivers
    12.2 Point-of-care Testing (POCT) for Inflammatory Market Restraints
    12.3 Point-of-care Testing (POCT) for Inflammatory Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Point-of-care Testing (POCT) for Inflammatory and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Inflammatory
    13.3 Point-of-care Testing (POCT) for Inflammatory Production Process
    13.4 Point-of-care Testing (POCT) for Inflammatory Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Point-of-care Testing (POCT) for Inflammatory Typical Distributors
    14.3 Point-of-care Testing (POCT) for Inflammatory Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Roche Basic Information, Manufacturing Base and Competitors
    Table 4. Roche Major Business
    Table 5. Roche Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 6. Roche Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Roche Recent Developments/Updates
    Table 8. Abbott Basic Information, Manufacturing Base and Competitors
    Table 9. Abbott Major Business
    Table 10. Abbott Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 11. Abbott Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Abbott Recent Developments/Updates
    Table 13. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
    Table 14. Siemens Healthineers Major Business
    Table 15. Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 16. Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Siemens Healthineers Recent Developments/Updates
    Table 18. BioMerieux Basic Information, Manufacturing Base and Competitors
    Table 19. BioMerieux Major Business
    Table 20. BioMerieux Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 21. BioMerieux Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. BioMerieux Recent Developments/Updates
    Table 23. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
    Table 24. Bio-Rad Laboratories Major Business
    Table 25. Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 26. Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Bio-Rad Laboratories Recent Developments/Updates
    Table 28. Assure Tech Basic Information, Manufacturing Base and Competitors
    Table 29. Assure Tech Major Business
    Table 30. Assure Tech Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 31. Assure Tech Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Assure Tech Recent Developments/Updates
    Table 33. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
    Table 34. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
    Table 35. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 36. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
    Table 38. Wuhan Easy Diagnosis Basic Information, Manufacturing Base and Competitors
    Table 39. Wuhan Easy Diagnosis Major Business
    Table 40. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 41. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Wuhan Easy Diagnosis Recent Developments/Updates
    Table 43. Getein Biotech Basic Information, Manufacturing Base and Competitors
    Table 44. Getein Biotech Major Business
    Table 45. Getein Biotech Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 46. Getein Biotech Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Getein Biotech Recent Developments/Updates
    Table 48. Beijing Hotgen Biotech Co.,ltd. Basic Information, Manufacturing Base and Competitors
    Table 49. Beijing Hotgen Biotech Co.,ltd. Major Business
    Table 50. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 51. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
    Table 53. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Basic Information, Manufacturing Base and Competitors
    Table 54. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Major Business
    Table 55. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 56. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments/Updates
    Table 58. Qingdao Hightop Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 59. Qingdao Hightop Biotech Co., Ltd. Major Business
    Table 60. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 61. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 62. Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
    Table 63. Goldsite Diagnostics Inc. Basic Information, Manufacturing Base and Competitors
    Table 64. Goldsite Diagnostics Inc. Major Business
    Table 65. Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 66. Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 67. Goldsite Diagnostics Inc. Recent Developments/Updates
    Table 68. Genrui Biotech Inc Basic Information, Manufacturing Base and Competitors
    Table 69. Genrui Biotech Inc Major Business
    Table 70. Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 71. Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 72. Genrui Biotech Inc Recent Developments/Updates
    Table 73. Hipro Biotechnology CO.,LTD Basic Information, Manufacturing Base and Competitors
    Table 74. Hipro Biotechnology CO.,LTD Major Business
    Table 75. Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 76. Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Hipro Biotechnology CO.,LTD Recent Developments/Updates
    Table 78. Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 79. Global Point-of-care Testing (POCT) for Inflammatory Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 80. Global Point-of-care Testing (POCT) for Inflammatory Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 81. Market Position of Manufacturers in Point-of-care Testing (POCT) for Inflammatory, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 82. Head Office and Point-of-care Testing (POCT) for Inflammatory Production Site of Key Manufacturer
    Table 83. Point-of-care Testing (POCT) for Inflammatory Market: Company Product Type Footprint
    Table 84. Point-of-care Testing (POCT) for Inflammatory Market: Company Product Application Footprint
    Table 85. Point-of-care Testing (POCT) for Inflammatory New Market Entrants and Barriers to Market Entry
    Table 86. Point-of-care Testing (POCT) for Inflammatory Mergers, Acquisition, Agreements, and Collaborations
    Table 87. Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Region (2019-2024) & (K Units)
    Table 88. Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Region (2025-2030) & (K Units)
    Table 89. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Region (2019-2024) & (USD Million)
    Table 90. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Region (2025-2030) & (USD Million)
    Table 91. Global Point-of-care Testing (POCT) for Inflammatory Average Price by Region (2019-2024) & (US$/Unit)
    Table 92. Global Point-of-care Testing (POCT) for Inflammatory Average Price by Region (2025-2030) & (US$/Unit)
    Table 93. Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2019-2024) & (K Units)
    Table 94. Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2025-2030) & (K Units)
    Table 95. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Type (2019-2024) & (USD Million)
    Table 96. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Type (2025-2030) & (USD Million)
    Table 97. Global Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2019-2024) & (US$/Unit)
    Table 98. Global Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2025-2030) & (US$/Unit)
    Table 99. Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2019-2024) & (K Units)
    Table 100. Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2025-2030) & (K Units)
    Table 101. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Application (2019-2024) & (USD Million)
    Table 102. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Application (2025-2030) & (USD Million)
    Table 103. Global Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2019-2024) & (US$/Unit)
    Table 104. Global Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2025-2030) & (US$/Unit)
    Table 105. North America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2019-2024) & (K Units)
    Table 106. North America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2025-2030) & (K Units)
    Table 107. North America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2019-2024) & (K Units)
    Table 108. North America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2025-2030) & (K Units)
    Table 109. North America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Country (2019-2024) & (K Units)
    Table 110. North America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Country (2025-2030) & (K Units)
    Table 111. North America Point-of-care Testing (POCT) for Inflammatory Consumption Value by Country (2019-2024) & (USD Million)
    Table 112. North America Point-of-care Testing (POCT) for Inflammatory Consumption Value by Country (2025-2030) & (USD Million)
    Table 113. Europe Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2019-2024) & (K Units)
    Table 114. Europe Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2025-2030) & (K Units)
    Table 115. Europe Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2019-2024) & (K Units)
    Table 116. Europe Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2025-2030) & (K Units)
    Table 117. Europe Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Country (2019-2024) & (K Units)
    Table 118. Europe Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Country (2025-2030) & (K Units)
    Table 119. Europe Point-of-care Testing (POCT) for Inflammatory Consumption Value by Country (2019-2024) & (USD Million)
    Table 120. Europe Point-of-care Testing (POCT) for Inflammatory Consumption Value by Country (2025-2030) & (USD Million)
    Table 121. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2019-2024) & (K Units)
    Table 122. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2025-2030) & (K Units)
    Table 123. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2019-2024) & (K Units)
    Table 124. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2025-2030) & (K Units)
    Table 125. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Region (2019-2024) & (K Units)
    Table 126. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Region (2025-2030) & (K Units)
    Table 127. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Consumption Value by Region (2019-2024) & (USD Million)
    Table 128. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Consumption Value by Region (2025-2030) & (USD Million)
    Table 129. South America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2019-2024) & (K Units)
    Table 130. South America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2025-2030) & (K Units)
    Table 131. South America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2019-2024) & (K Units)
    Table 132. South America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2025-2030) & (K Units)
    Table 133. South America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Country (2019-2024) & (K Units)
    Table 134. South America Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Country (2025-2030) & (K Units)
    Table 135. South America Point-of-care Testing (POCT) for Inflammatory Consumption Value by Country (2019-2024) & (USD Million)
    Table 136. South America Point-of-care Testing (POCT) for Inflammatory Consumption Value by Country (2025-2030) & (USD Million)
    Table 137. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2019-2024) & (K Units)
    Table 138. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Type (2025-2030) & (K Units)
    Table 139. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2019-2024) & (K Units)
    Table 140. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Application (2025-2030) & (K Units)
    Table 141. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Region (2019-2024) & (K Units)
    Table 142. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Sales Quantity by Region (2025-2030) & (K Units)
    Table 143. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Consumption Value by Region (2019-2024) & (USD Million)
    Table 144. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Consumption Value by Region (2025-2030) & (USD Million)
    Table 145. Point-of-care Testing (POCT) for Inflammatory Raw Material
    Table 146. Key Manufacturers of Point-of-care Testing (POCT) for Inflammatory Raw Materials
    Table 147. Point-of-care Testing (POCT) for Inflammatory Typical Distributors
    Table 148. Point-of-care Testing (POCT) for Inflammatory Typical Customers
List of Figures
    Figure 1. Point-of-care Testing (POCT) for Inflammatory Picture
    Figure 2. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value Market Share by Type in 2023
    Figure 4. Based on Immunochromatography Examples
    Figure 5. Based on Chemiluminescence Examples
    Figure 6. Based on Microfluidic Chip Examples
    Figure 7. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 8. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value Market Share by Application in 2023
    Figure 9. C-Reactive Protein (CRP) Test Examples
    Figure 10. Procalcitonin (PCT) Test Examples
    Figure 11. Interleukin 6 (IL-6) Test Examples
    Figure 12. Serum amyloid A (SAA) Test Examples
    Figure 13. Others Examples
    Figure 14. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 15. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 16. Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity (2019-2030) & (K Units)
    Figure 17. Global Point-of-care Testing (POCT) for Inflammatory Average Price (2019-2030) & (US$/Unit)
    Figure 18. Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Manufacturer in 2023
    Figure 19. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value Market Share by Manufacturer in 2023
    Figure 20. Producer Shipments of Point-of-care Testing (POCT) for Inflammatory by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 21. Top 3 Point-of-care Testing (POCT) for Inflammatory Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Top 6 Point-of-care Testing (POCT) for Inflammatory Manufacturer (Consumption Value) Market Share in 2023
    Figure 23. Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Region (2019-2030)
    Figure 24. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value Market Share by Region (2019-2030)
    Figure 25. North America Point-of-care Testing (POCT) for Inflammatory Consumption Value (2019-2030) & (USD Million)
    Figure 26. Europe Point-of-care Testing (POCT) for Inflammatory Consumption Value (2019-2030) & (USD Million)
    Figure 27. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Consumption Value (2019-2030) & (USD Million)
    Figure 28. South America Point-of-care Testing (POCT) for Inflammatory Consumption Value (2019-2030) & (USD Million)
    Figure 29. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Consumption Value (2019-2030) & (USD Million)
    Figure 30. Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Type (2019-2030)
    Figure 31. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value Market Share by Type (2019-2030)
    Figure 32. Global Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2019-2030) & (US$/Unit)
    Figure 33. Global Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Application (2019-2030)
    Figure 34. Global Point-of-care Testing (POCT) for Inflammatory Consumption Value Market Share by Application (2019-2030)
    Figure 35. Global Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2019-2030) & (US$/Unit)
    Figure 36. North America Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Type (2019-2030)
    Figure 37. North America Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Application (2019-2030)
    Figure 38. North America Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Country (2019-2030)
    Figure 39. North America Point-of-care Testing (POCT) for Inflammatory Consumption Value Market Share by Country (2019-2030)
    Figure 40. United States Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Canada Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Mexico Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 43. Europe Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Type (2019-2030)
    Figure 44. Europe Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Application (2019-2030)
    Figure 45. Europe Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Country (2019-2030)
    Figure 46. Europe Point-of-care Testing (POCT) for Inflammatory Consumption Value Market Share by Country (2019-2030)
    Figure 47. Germany Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. France Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. United Kingdom Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Russia Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Italy Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 52. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Type (2019-2030)
    Figure 53. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Application (2019-2030)
    Figure 54. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Region (2019-2030)
    Figure 55. Asia-Pacific Point-of-care Testing (POCT) for Inflammatory Consumption Value Market Share by Region (2019-2030)
    Figure 56. China Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Japan Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Korea Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. India Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Southeast Asia Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. Australia Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 62. South America Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Type (2019-2030)
    Figure 63. South America Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Application (2019-2030)
    Figure 64. South America Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Country (2019-2030)
    Figure 65. South America Point-of-care Testing (POCT) for Inflammatory Consumption Value Market Share by Country (2019-2030)
    Figure 66. Brazil Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Argentina Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 68. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Type (2019-2030)
    Figure 69. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Application (2019-2030)
    Figure 70. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Sales Quantity Market Share by Region (2019-2030)
    Figure 71. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Consumption Value Market Share by Region (2019-2030)
    Figure 72. Turkey Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Egypt Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. Saudi Arabia Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. South Africa Point-of-care Testing (POCT) for Inflammatory Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 76. Point-of-care Testing (POCT) for Inflammatory Market Drivers
    Figure 77. Point-of-care Testing (POCT) for Inflammatory Market Restraints
    Figure 78. Point-of-care Testing (POCT) for Inflammatory Market Trends
    Figure 79. Porters Five Forces Analysis
    Figure 80. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Inflammatory in 2023
    Figure 81. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Inflammatory
    Figure 82. Point-of-care Testing (POCT) for Inflammatory Industrial Chain
    Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 84. Direct Channel Pros & Cons
    Figure 85. Indirect Channel Pros & Cons
    Figure 86. Methodology
    Figure 87. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Roche
Abbott
Siemens Healthineers
BioMerieux
Bio-Rad Laboratories
Assure Tech
Guangzhou Wondfo Biotech Co.,Ltd.
Wuhan Easy Diagnosis
Getein Biotech
Beijing Hotgen Biotech Co.,ltd.
Shanghai Upper Bio-Tech Pharma Co.,Ltd.
Qingdao Hightop Biotech Co., Ltd.
Goldsite Diagnostics Inc.
Genrui Biotech Inc
Hipro Biotechnology CO.,LTD

Related Reports

Global Point-of-care Testing (POCT) for Inflammatory Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Point-of-care Testing (POCT) for Inflammatory Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 28 Feb 2023

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Point-of-care Testing (POCT) for Inflammatory market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Point-of-care Testing (POCT) for Inflammatory Supply, Demand and Key Producers, 2023-2029

Global Point-of-care Testing (POCT) for Inflammatory Supply, Demand and Key Producers, 2023-2029

date 28 Feb 2023

date Medical Devices & Consumables

The global Point-of-care Testing (POCT) for Inflammatory market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Point-of-care Testing (POCT) for Inflammatory Supply, Demand and Key Producers, 2024-2030

Global Point-of-care Testing (POCT) for Inflammatory Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Medical Devices & Consumables

The global Point-of-care Testing (POCT) for Inflammatory market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Point-of-care Testing (POCT) for Inflammatory

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>